Octreotide

• Catalog No.: Octreotide
• CAS Number: 83150-76-9
• M. F.: C49H66N10O10S2
• M. W.: 1019.23934

SYNONYMS

• IUPAC name: (4R,7S,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
• IUPAC Traditional name: (4R,7S,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
• Brand Name: Sandostatin

DATABASE IDS

• Wikipedia Title: Octreotide
• Chemspider ID: 10482007
• PubChem CID: 54373
• ATC CODE: H01CB02
• CHEMBL: 1680
• Unique Ingredient Identifier: RWM8CCW8GP
• CAS Number: 83150-76-9
• KEGG ID: D00442
• DrugBank ID: DB00104

PROPERTIES

• Admin Routes: Subcutaneous, intramuscular, intravenous
• Bioavailability: 100%; I.M.: 60% to 63% of subcutaneous dose
• Half Life: 1.7–1.9 hours
• Legal Status: Rx
• Metabolism: Hepatic
• Pregnancy Category: B (US)
• Protein Bound: 65%